JP2024079701A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024079701A5 JP2024079701A5 JP2024035073A JP2024035073A JP2024079701A5 JP 2024079701 A5 JP2024079701 A5 JP 2024079701A5 JP 2024035073 A JP2024035073 A JP 2024035073A JP 2024035073 A JP2024035073 A JP 2024035073A JP 2024079701 A5 JP2024079701 A5 JP 2024079701A5
- Authority
- JP
- Japan
- Prior art keywords
- risk
- insulin
- basal rate
- blood glucose
- set point
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 60
- 102000004877 Insulin Human genes 0.000 claims 30
- 108090001061 Insulin Proteins 0.000 claims 30
- 229940125396 insulin Drugs 0.000 claims 30
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 17
- 239000008280 blood Substances 0.000 claims 17
- 210000004369 blood Anatomy 0.000 claims 17
- 239000008103 glucose Substances 0.000 claims 17
- 230000002218 hypoglycaemic effect Effects 0.000 claims 14
- 208000013016 Hypoglycemia Diseases 0.000 claims 9
- 238000005259 measurement Methods 0.000 claims 9
- 230000003345 hyperglycaemic effect Effects 0.000 claims 8
- 201000001421 hyperglycemia Diseases 0.000 claims 5
- 238000004590 computer program Methods 0.000 claims 3
- 230000002641 glycemic effect Effects 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 210000000496 pancreas Anatomy 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762459100P | 2017-02-15 | 2017-02-15 | |
| US62/459,100 | 2017-02-15 | ||
| JP2019545370A JP2020511202A (ja) | 2017-02-15 | 2018-02-15 | 閉ループ人工膵臓システム用の基礎レートプロファイル適応アルゴリズムのためのシステム、方法、及びコンピュータ可読媒体 |
| PCT/US2018/018414 WO2018152358A1 (en) | 2017-02-15 | 2018-02-15 | System, method, and computer readable medium for a basal rate profile adaptation algorithm for closed-loop artificial pancreas systems |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019545370A Division JP2020511202A (ja) | 2017-02-15 | 2018-02-15 | 閉ループ人工膵臓システム用の基礎レートプロファイル適応アルゴリズムのためのシステム、方法、及びコンピュータ可読媒体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024079701A JP2024079701A (ja) | 2024-06-11 |
| JP2024079701A5 true JP2024079701A5 (enExample) | 2024-10-18 |
Family
ID=63169641
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019545370A Pending JP2020511202A (ja) | 2017-02-15 | 2018-02-15 | 閉ループ人工膵臓システム用の基礎レートプロファイル適応アルゴリズムのためのシステム、方法、及びコンピュータ可読媒体 |
| JP2024035073A Pending JP2024079701A (ja) | 2017-02-15 | 2024-03-07 | 閉ループ人工膵臓システム用の基礎レートプロファイル適応アルゴリズムのためのシステム、方法、及びコンピュータ可読媒体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019545370A Pending JP2020511202A (ja) | 2017-02-15 | 2018-02-15 | 閉ループ人工膵臓システム用の基礎レートプロファイル適応アルゴリズムのためのシステム、方法、及びコンピュータ可読媒体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20200046268A1 (enExample) |
| EP (1) | EP3582831A4 (enExample) |
| JP (2) | JP2020511202A (enExample) |
| AU (2) | AU2018221048B2 (enExample) |
| CA (1) | CA3053502A1 (enExample) |
| WO (1) | WO2018152358A1 (enExample) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8417311B2 (en) | 2008-09-12 | 2013-04-09 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
| US7959598B2 (en) | 2008-08-20 | 2011-06-14 | Asante Solutions, Inc. | Infusion pump systems and methods |
| US9561324B2 (en) | 2013-07-19 | 2017-02-07 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
| GB2523989B (en) | 2014-01-30 | 2020-07-29 | Insulet Netherlands B V | Therapeutic product delivery system and method of pairing |
| AU2016219961B2 (en) | 2015-02-18 | 2020-07-02 | Insulet Corporation | Fluid delivery and infusion devices, and methods of use thereof |
| HK1257246A1 (zh) | 2016-01-13 | 2019-10-18 | Bigfoot Biomedical, Inc. | 糖尿病管理系统的用户界面 |
| US10307538B2 (en) | 2016-01-14 | 2019-06-04 | Bigfoot Biomedical, Inc. | Adjusting insulin delivery rates |
| HK1256995A1 (zh) | 2016-01-14 | 2019-10-11 | Bigfoot Biomedical, Inc. | 药物输送设备、系统和方法中的阻塞解决方案 |
| US12383166B2 (en) | 2016-05-23 | 2025-08-12 | Insulet Corporation | Insulin delivery system and methods with risk-based set points |
| WO2018058041A1 (en) | 2016-09-23 | 2018-03-29 | Insulet Corporation | Fluid delivery device with sensor |
| US11096624B2 (en) | 2016-12-12 | 2021-08-24 | Bigfoot Biomedical, Inc. | Alarms and alerts for medication delivery devices and systems |
| US10758675B2 (en) | 2017-01-13 | 2020-09-01 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| EP3568860B1 (en) | 2017-01-13 | 2025-12-10 | Insulet Corporation | Insulin delivery methods, systems and devices |
| US10500334B2 (en) | 2017-01-13 | 2019-12-10 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| US10881793B2 (en) | 2017-01-13 | 2021-01-05 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| US11027063B2 (en) | 2017-01-13 | 2021-06-08 | Bigfoot Biomedical, Inc. | Insulin delivery methods, systems and devices |
| USD928199S1 (en) | 2018-04-02 | 2021-08-17 | Bigfoot Biomedical, Inc. | Medication delivery device with icons |
| US11565043B2 (en) | 2018-05-04 | 2023-01-31 | Insulet Corporation | Safety constraints for a control algorithm based drug delivery system |
| CN112789070A (zh) | 2018-09-28 | 2021-05-11 | 英赛罗公司 | 人造胰腺系统的活动模式 |
| US11565039B2 (en) | 2018-10-11 | 2023-01-31 | Insulet Corporation | Event detection for drug delivery system |
| US10736037B2 (en) * | 2018-12-26 | 2020-08-04 | Tandem Diabetes Care, Inc. | Methods of wireless communication in an infusion pump system |
| USD920343S1 (en) | 2019-01-09 | 2021-05-25 | Bigfoot Biomedical, Inc. | Display screen or portion thereof with graphical user interface associated with insulin delivery |
| FR3099043B1 (fr) * | 2019-07-25 | 2023-11-03 | Commissariat Energie Atomique | Système automatisé de régulation de glycémie |
| US11801344B2 (en) | 2019-09-13 | 2023-10-31 | Insulet Corporation | Blood glucose rate of change modulation of meal and correction insulin bolus quantity |
| US11935637B2 (en) | 2019-09-27 | 2024-03-19 | Insulet Corporation | Onboarding and total daily insulin adaptivity |
| EP4070333A1 (en) * | 2019-12-03 | 2022-10-12 | Bigfoot Biomedical, Inc. | Determining total daily basal dose mismatch |
| US20230005587A1 (en) * | 2019-12-03 | 2023-01-05 | Bigfoot Biomedical, Inc. | Determining whether adjustments of insulin therapy recommendations are being taken into account |
| EP4069082B1 (en) | 2019-12-06 | 2024-06-05 | Insulet Corporation | Techniques and devices providing adaptivity and personalization in diabetes treatment |
| US11833329B2 (en) | 2019-12-20 | 2023-12-05 | Insulet Corporation | Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns |
| AU2021206190A1 (en) | 2020-01-06 | 2022-08-18 | Insulet Corporation | Prediction of meal and/or exercise events based on persistent residuals |
| EP4100958A1 (en) | 2020-02-03 | 2022-12-14 | Insulet Corporation | Use of fuzzy logic in predicting user behavior affecting blood glucose concentration |
| US11551802B2 (en) | 2020-02-11 | 2023-01-10 | Insulet Corporation | Early meal detection and calorie intake detection |
| US11986630B2 (en) | 2020-02-12 | 2024-05-21 | Insulet Corporation | Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk |
| US11547800B2 (en) | 2020-02-12 | 2023-01-10 | Insulet Corporation | User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system |
| US11324889B2 (en) | 2020-02-14 | 2022-05-10 | Insulet Corporation | Compensation for missing readings from a glucose monitor in an automated insulin delivery system |
| US12495994B2 (en) | 2020-02-20 | 2025-12-16 | Insulet Corporation | Meal bolus subcategories in model based insulin therapy |
| US11607493B2 (en) | 2020-04-06 | 2023-03-21 | Insulet Corporation | Initial total daily insulin setting for user onboarding |
| US12121700B2 (en) | 2020-07-22 | 2024-10-22 | Insulet Corporation | Open-loop insulin delivery basal parameters based on insulin delivery records |
| US11684716B2 (en) | 2020-07-31 | 2023-06-27 | Insulet Corporation | Techniques to reduce risk of occlusions in drug delivery systems |
| US12128215B2 (en) | 2020-09-30 | 2024-10-29 | Insulet Corporation | Drug delivery device with integrated optical-based glucose monitor |
| WO2022072618A1 (en) | 2020-09-30 | 2022-04-07 | Insulet Corporation | Secure wireless communications between a glucose monitor and other devices |
| JP7785070B2 (ja) * | 2020-10-14 | 2025-12-12 | ユニバーシティ オブ バージニア パテント ファンデーション | 報知されない血糖揺らぎの原因後の血糖反応を改善する閉ループ制御の方法及びシステム |
| US20220192591A1 (en) * | 2020-12-23 | 2022-06-23 | Dexcom, Inc. | Bolus advisor with correction boluses based on risk, carb-free bolus recommender, and meal acknowledgement |
| US20220241503A1 (en) * | 2021-01-29 | 2022-08-04 | Insulet Corporation | Techniques and devices that adapt basal profiles for drug delivery applications |
| US11160925B1 (en) | 2021-01-29 | 2021-11-02 | Insulet Corporation | Automatic drug delivery system for delivery of a GLP-1 therapeutic |
| US12485274B2 (en) | 2021-03-08 | 2025-12-02 | Samsung Electronics Co., Ltd. | Apparatus and method with electrical stimulus |
| US12431229B2 (en) | 2021-03-10 | 2025-09-30 | Insulet Corporation | Medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions |
| US11904140B2 (en) | 2021-03-10 | 2024-02-20 | Insulet Corporation | Adaptable asymmetric medicament cost component in a control system for medicament delivery |
| EP4309188A4 (en) * | 2021-03-19 | 2025-02-26 | Horton, William B. | SYSTEM AND METHOD FOR IDENTIFYING AND PREDICTING HYPOGLYCEMIC RISK |
| US12496398B2 (en) | 2021-05-28 | 2025-12-16 | Insulet Corporation | Threshold based automatic glucose control response |
| US12406760B2 (en) | 2021-06-07 | 2025-09-02 | Insulet Corporation | Exercise safety prediction based on physiological conditions |
| US11792714B2 (en) * | 2021-06-16 | 2023-10-17 | Medtronic Minimed, Inc. | Medicine administration in dynamic networks |
| US12514980B2 (en) | 2021-06-30 | 2026-01-06 | Insulet Corporation | Adjustment of medicament delivery by a medicament delivery device based on menstrual cycle phase |
| US12521486B2 (en) | 2021-07-16 | 2026-01-13 | Insulet Corporation | Method for modification of insulin delivery during pregnancy in automatic insulin delivery systems |
| US11738144B2 (en) | 2021-09-27 | 2023-08-29 | Insulet Corporation | Techniques enabling adaptation of parameters in aid systems by user input |
| US11439754B1 (en) | 2021-12-01 | 2022-09-13 | Insulet Corporation | Optimizing embedded formulations for drug delivery |
| WO2024147928A1 (en) | 2023-01-06 | 2024-07-11 | Insulet Corporation | Automatically or manually initiated meal bolus delivery with subsequent automatic safety constraint relaxation |
| US20250288740A1 (en) * | 2024-03-18 | 2025-09-18 | Insulet Corporation | System and methods to customize modes into actionable pump settings |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1728468A1 (de) * | 2005-06-04 | 2006-12-06 | Roche Diagnostics GmbH | Bewertung von Werten der Blutglucosekonzentration zur Einstellung der Insulindosierung |
| US20080269723A1 (en) * | 2007-04-25 | 2008-10-30 | Medtronic Minimed, Inc. | Closed loop/semi-closed loop therapy modification system |
| US20080269714A1 (en) * | 2007-04-25 | 2008-10-30 | Medtronic Minimed, Inc. | Closed loop/semi-closed loop therapy modification system |
| US8417311B2 (en) * | 2008-09-12 | 2013-04-09 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
| EP4468309A3 (en) * | 2007-10-09 | 2024-12-11 | DexCom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
| WO2009049252A1 (en) * | 2007-10-10 | 2009-04-16 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
| WO2011031351A1 (en) * | 2009-09-14 | 2011-03-17 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
| DK2483824T3 (da) * | 2009-09-30 | 2017-11-27 | Dreamed Diabetes Ltd | Monitoreringsanordning til styring af insulinindgivelse |
| CA3054707C (en) * | 2010-01-22 | 2022-06-07 | Deka Products Limited Partnership | Infusion pump apparatus, method and system |
| WO2012178134A2 (en) * | 2011-06-23 | 2012-12-27 | University Of Virginia Patent Foundation | Unified platform for monitoring and control of blood glucose levels in diabetic patients |
| US20140012118A1 (en) * | 2012-07-09 | 2014-01-09 | Dexcom, Inc. | Systems and methods for leveraging smartphone features in continuous glucose monitoring |
| US10112011B2 (en) * | 2013-07-19 | 2018-10-30 | Dexcom, Inc. | Time averaged basal rate optimizer |
| CN103418053B (zh) * | 2013-07-24 | 2015-03-11 | 上海中医药大学附属龙华医院 | 个体化胰岛素治疗泵及其基础输注率优化方法 |
| WO2016133879A1 (en) * | 2015-02-16 | 2016-08-25 | University Of Virginia Patent Foundation | Method, system and computer readable medium for assessing actionable glycemic risk |
-
2018
- 2018-02-15 CA CA3053502A patent/CA3053502A1/en active Pending
- 2018-02-15 WO PCT/US2018/018414 patent/WO2018152358A1/en not_active Ceased
- 2018-02-15 US US16/486,049 patent/US20200046268A1/en active Pending
- 2018-02-15 EP EP18754079.4A patent/EP3582831A4/en active Pending
- 2018-02-15 AU AU2018221048A patent/AU2018221048B2/en active Active
- 2018-02-15 JP JP2019545370A patent/JP2020511202A/ja active Pending
-
2023
- 2023-11-14 AU AU2023266248A patent/AU2023266248B2/en active Active
-
2024
- 2024-03-07 JP JP2024035073A patent/JP2024079701A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024079701A5 (enExample) | ||
| JP7457072B2 (ja) | 生理的グルコースの閉ループ制御 | |
| US11605461B2 (en) | Risk-based control-to-range blood glucose diabetes management device | |
| CN110869075B (zh) | 人工胰岛系统中的胰岛素残余活性含量计算 | |
| AU2017275392B2 (en) | Control-to-range aggressiveness | |
| RU2019136677A (ru) | Система управления течением диабета с автоматическим управлением базальным введением инсулина и ручным управлением болюсным введением инсулина | |
| RU2721878C2 (ru) | Способы и системы для анализа данных о содержании глюкозы, измеренных у больного диабетом | |
| EP2986215B1 (en) | Discretionary insulin delivery systems and methods | |
| WO2015056259A1 (en) | System and method for improved artificial pancreas management | |
| RU2016115709A (ru) | Способ и система контроля коэффициента настройки в связи с заменой датчика для контроллера с обратной связью при искусственной поджелудочной железе | |
| KR102398749B1 (ko) | 환자의 혈당 조절용 자동 시스템 | |
| JP7290624B2 (ja) | 閉ループ血糖制御システム及び閉ループ血糖制御システムの作動方法 | |
| KR102398748B1 (ko) | 환자의 혈당 조절용 자동 시스템 | |
| AU2018235368A1 (en) | System and method for improving the drug therapy management | |
| CN114173644B (zh) | 动态等效体载估计器 | |
| US12495994B2 (en) | Meal bolus subcategories in model based insulin therapy | |
| WO2018042147A1 (en) | Automatic closed-loop glucose control with an adaptive meal bolus calculator | |
| EP4075440A1 (en) | Meal bolus subcategories in model based insulin therapy | |
| HK40006648A (en) | Control-to-range aggressiveness |